The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells

References

• Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, Vasavada R, Stewart AF. Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev (2006), 27, 356–370.
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA.Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004), 429, 41–46.
   PubMed Web of Science ®Google Scholar
• Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal β-cell mass. J Clin Invest (2004), 114, 963–968.
   PubMed Web of Science ®Google Scholar
• Kushner JA.Beta-cell growth: an unusual paradigm of organogenesis that is cyclin D2/Cdk4 dependent. Cell Cycle (2006), 5, 234–237.
   PubMed Web of Science ®Google Scholar
• Ackermann AM, Gannon M. Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J Mol Endocrinol (2007) 38,193–206.
   PubMed Web of Science ®Google Scholar
• Heit JJ, Karnik SK, Kim SK. Intrinsic regulators of pancreatic β-cell proliferation. Annu Rev Cell Dev Biol (2006), 22, 311–338.
   PubMed Web of Science ®Google Scholar
• Glauser DA, Schlegel W. The emerging role of FOXO transcription factors in pancreatic β-cells. J Endocrinol (2007), 193, 195–207.
   PubMedGoogle Scholar
• Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene (2005), 24, 7410–7425.
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999), 96, 857–868.
   PubMed Web of Science ®Google Scholar
• Buteau J., Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic β-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem (2007), 282, 287–293.
   PubMed Web of Science ®Google Scholar
• Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem (2006) 281, 1091–1098.
   PubMedGoogle Scholar
• Kitamura, T, Nakae J, Kitamura Y, Kido Y, Biggs WH 3rd, Wright CV, White MF, Arden KC, Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β-cell growth. J Clin Invest (2002), 110, 1839–1847.
   PubMed Web of Science ®Google Scholar
• Martinez SC, Cras-Meneur C, Bernal-Mizrachi E, Permutt MA. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet β-cell. Diabetes (2006), 55, 1581–1591.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D. Role of the forkhead protein FoxO1 in β-cell compensation to insulin resistance. J Clin Invest (2006), 116, 775–782.
   PubMedGoogle Scholar
• Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K. Establishment of a pancreatic β-cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology (1990), 127, 126–132.
   PubMed Web of Science ®Google Scholar
• Glauser DA, Schlegel W. Mechanisms of transcriptional regulation underlying temporal integration of signals. Nucleic Acids Research (2006), 34, 5175–5183.
   Google Scholar
• Glauser DA, Schlegel W. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic β-cells. FASEB J (2007), 21, 3240–3249.
   PubMed Web of Science ®Google Scholar
• Glauser DA, Brun T, Gauthier BR, Schlegel W. Transcriptional response of pancreatic β-cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes. BMC Mol Biol (2007), 8, 54.
   Google Scholar
• Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell (2002), 2, 81–91.
   PubMed Web of Science ®Google Scholar
• Dent AL, Vasanwala FH, Toney LM. Regulation of gene expression by the proto-oncogene BCL-6. Crit Rev Oncol Hematol (2002), 41, 1–9.
   PubMedGoogle Scholar
• Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene (2003), 22, 507–516.
   PubMedGoogle Scholar
• Fernandez de Mattos S, Essafi A, Soeiro I, Pietersen AM, Birkenkamp KU, Edwards CS, Martino A, Nelson BH, Francis JM, Jones MC, Brosens JJ, Coffer PJ, Lam EW. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol Cell Biol (2004), 24, 10058–10071.
   PubMedGoogle Scholar
• Lee CH, Melchers M, Wang H, Torrey TA, Slota R, Qi CF, Kim JY, Lugar P, Kong HJ, Farrington L, van der Zouwen B, Zhou JX, Lougaris V, Lipsky PE, Grammer AC, Morse HC 3rd. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2006), 203, 63–72.
   PubMed Web of Science ®Google Scholar
• Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci USA (2005), 102, 11278–11283.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay A, Tate SA, Beswick RW, Wagner SD, Ko Ferrigno P. A peptide aptamer to antagonize BCL-6 function. Oncogene (2006), 25, 2223–2233.
   PubMed Web of Science ®Google Scholar
• Calnan DR, Brunet A. The FoxO code. Oncogene (2008), 27, 2276–2288.
   PubMed Web of Science ®Google Scholar
• Park Y, Maizels ET, Feiger ZJ, Alam H, Peters CA, Woodruff TK, Unterman TG, Lee EJ, Jameson JL, Hunzicker-Dunn M. Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. J Biol Chem (2005), 280, 9135–9148.
   PubMed Web of Science ®Google Scholar
• Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D, Van de Casteele M. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol (2003), 30, 151–161.
   PubMed Web of Science ®Google Scholar
• Fatrai F, Elghazi L, Balcazar N, Cras-Méneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E. Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes (2006), 55, 318–325.
   PubMed Web of Science ®Google Scholar
• Friedrichsen BN, Neubauer N, Lee YC, Gram VK, Blume N, Petersen JS, Nielsen JH, Møldrup, A. Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J of Endo (2006), 188, 481–492.
   PubMed Web of Science ®Google Scholar
• Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem (2008), 283, 8723–8735.
   PubMed Web of Science ®Google Scholar
• Agudo J, Ayuso E, Jimenez V, Salavert A, Casellas A, Tafuro S, Haurigot V, Ruberte J, Segovia JC, Bueren J, Bosch F. IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia (2008), 51, 1862–1872.
   Google Scholar
• Glauser DA, Schlegel W. Foxo proteins in pancreatic β-cells as potential therapeutic targets in diabetes. Exp Rev Endocrinol Metab (2008), 3, 175–185.
   PubMedGoogle Scholar
• Gross DN, van den Heuvel APJ, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene (2008), 27, 2320–2336.
   PubMed Web of Science ®Google Scholar